Advanced search
Publication Cover
OncoImmunology Volume 10, 2021 - Issue 1
Submit an article Journal homepage
4,309
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Tumor immune infiltration estimated from gene expression profiles predicts colorectal cancer relapse

Yasmin Kamala Department of Biomedical Data Sciences, Geisel School of Medicine at Dartmouth, Hanover, NH, USAView further author information
,
Dennis Dwana Department of Biomedical Data Sciences, Geisel School of Medicine at Dartmouth, Hanover, NH, USAView further author information
,
Hannah J. Hoehnb Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USAView further author information
,
Rebeca Sanz-Pamplonac Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology (ICO), ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain;d Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, SpainView further author information
,
M. Henar Alonsoc Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology (ICO), ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain;d Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain;e Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, SpainView further author information
,
Victor Morenoc Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology (ICO), ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain;d Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain;e Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, SpainORCID Iconhttps://orcid.org/0000-0002-2818-5487View further author information
ORCID Icon,
Chao Chengf Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA;g Department of Medicine, Baylor College of Medicine, Houston, TX, USA;h Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USAView further author information
,
Michael J. Schelli Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Columbus, OH, USAView further author information
,
Youngchul Kimi Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Columbus, OH, USAView further author information
,
Seth I. Felderj Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research InstituteView further author information
,
Hedy S. Rennertk Department of Community Medicine & Epidemiology, Lady Davis Carmel Medical Center, Ruth & Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology;l Steve and Cindy Rasmussen Institute for Genomic Medicine, Lady Davis Carmel Medical Center and Technion Faculty of Medicine, Clalit National Cancer Control Center, Haifa, IsraelView further author information
,
Marilena Melasm Department of Medical Oncology and Therapeutics Research, Center for Precision Medicine, City of Hope National Medical Center, Duarte, CA, USA;n Nationwide Children’s Hospital, Columbus, OH, USAView further author information
,
Charalampos Lazarism Department of Medical Oncology and Therapeutics Research, Center for Precision Medicine, City of Hope National Medical Center, Duarte, CA, USA;o Whitehead Institute for Biomedical Research, Cambridge, MA, USA;p Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USAView further author information
,
Joseph D. Bonnerq Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USAView further author information
,
Erin M. Siegelr Cancer Epidemiology Program, H. Lee Moffitt Cancer Center and Research InstituteView further author information
,
David Shibatas Department of Surgery, University of Tennessee Health Science Center, Memphis, TN, USAView further author information
,
Gad Rennertk Department of Community Medicine & Epidemiology, Lady Davis Carmel Medical Center, Ruth & Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology;l Steve and Cindy Rasmussen Institute for Genomic Medicine, Lady Davis Carmel Medical Center and Technion Faculty of Medicine, Clalit National Cancer Control Center, Haifa, IsraelView further author information
,
Stephen B. Gruberq Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USAView further author information
,
H. Robert Frosta Department of Biomedical Data Sciences, Geisel School of Medicine at Dartmouth, Hanover, NH, USAView further author information
,
Christopher I. Amosa Department of Biomedical Data Sciences, Geisel School of Medicine at Dartmouth, Hanover, NH, USA;g Department of Medicine, Baylor College of Medicine, Houston, TX, USA;h Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USAView further author information
&
Stephanie L. Schmitb Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA;j Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research InstituteCorrespondence[email protected]
View further author information
 show all
Article: 1862529 | Received 20 Nov 2019, Accepted 01 Dec 2020, Published online: 09 Mar 2021

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Killian Carnet Le Provost, Oliver Kepp, Guido Kroemer & Lucillia Bezu. (2023) Trial watch: beta-blockers in cancer therapy. OncoImmunology 12:1.
Read now
Michele Simbolo, Samantha Bersani, Caterina Vicentini, Sergio V. Taormina, Chiara Ciaparrone, Fabio Bagante, Borislav Rusev, Giovanni Centonze, Marina Montresor, Matteo Brunelli, Serena Pedron, Andrea Mafficini, Gaetano Paolino, Paola Mattiolo, Simone Conci, Massimo Milione, Alfredo Guglielmi, Andrea Ruzzenente, Aldo Scarpa & Claudio Luchini. (2021) Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumors display divergent genomic and transcriptomic profiles. Expert Opinion on Therapeutic Targets 25:12, pages 1095-1105.
Read now

Articles from other publishers (8)

Stephanie L. Schmit, Ya-Yu Tsai, Joseph D. Bonner, Rebeca Sanz-Pamplona, Amit D. Joshi, Tomotaka Ugai, Sidney S. Lindsey, Marilena Melas, Kevin J. McDonnell, Gregory E. Idos, Christopher P. Walker, Chenxu Qu, W. Martin Kast, Diane M. Da Silva, Jonathan N. Glickman, Andrew T. Chan, Marios Giannakis, Jonathan A. Nowak, Hedy S. Rennert, Harlan S. Robins, Shuji Ogino, Joel K. Greenson, Victor Moreno, Gad Rennert & Stephen B. Gruber. (2024) Germline genetic regulation of the colorectal tumor immune microenvironment. BMC Genomics 25:1.
Crossref
Carlos Eduardo Bonilla, Paola Montenegro, Juan Manuel O’Connor, Ovidio Hernando-Requejo, Enrique Aranda, José Pinto Llerena, Alejandra Llontop, Jorge Gallardo Escobar, María del Consuelo Díaz Romero, Yicel Bautista Hernández, Begoña Graña Suárez, Emilio J. Batagelj, Ahmad Wali Mushtaq & Jesús García-Foncillas. (2023) Ibero-American Consensus Review and Incorporation of New Biomarkers for Clinical Practice in Colorectal Cancer. Cancers 15:17, pages 4373.
Crossref
Ferran Moratalla-Navarro, Anna Díez-Villanueva, Ainhoa Garcia-Serrano, Adrià Closa, David Cordero, Xavier Solé, Elisabet Guinó, Rebeca Sanz-Pamplona, Xavier Sanjuan, Cristina Santos, Sebastiano Biondo, Ramón Salazar & Victor Moreno. (2023) Identification of a Twelve-microRNA Signature with Prognostic Value in Stage II Microsatellite Stable Colon Cancer. Cancers 15:13, pages 3301.
Crossref
Yuan Lin, Ying Zhang, Zhouting Tuo, Liang Gao, Demao Ding, Liangkuan Bi, Dexin Yu, Zhengmei Lv, Jiani Wang & Xin Chen. (2023) ORC6, a novel prognostic biomarker, correlates with T regulatory cell infiltration in prostate adenocarcinoma: a pan-cancer analysis. BMC Cancer 23:1.
Crossref
Zhanyong Ge & Delei Song. (2022) A five ferroptosis-related genes risk score for prognostic prediction of osteosarcoma. Medicine 101:50, pages e32083.
Crossref
Pilar M. Lanuza, M. Henar Alonso, Sandra Hidalgo, Iratxe Uranga-Murillo, Sandra García-Mulero, Raquel Arnau, Cristina Santos, Xavier Sanjuan, Llipsy Santiago, Laura Comas, Sergio Redrado, Roberto Pazo-Cid, M. Jose Agustin-Ferrández, Paula Jaime-Sánchez, Cecilia Pesini, Eva M. Gálvez, Ariel Ramírez-Labrada, Maykel Arias, Rebeca Sanz-Pamplona & Julián Pardo. (2022) Adoptive NK Cell Transfer as a Treatment in Colorectal Cancer Patients: Analyses of Tumour Cell Determinants Correlating With Efficacy In Vitro and In Vivo. Frontiers in Immunology 13.
Crossref
Jia-Hong Chen, Alexander T. H. Wu, Bashir Lawal, David T. W. Tzeng, Jih-Chin Lee, Ching-Liang Ho & Tsu-Yi Chao. (2021) Identification of Cancer Hub Gene Signatures Associated with Immune-Suppressive Tumor Microenvironment and Ovatodiolide as a Potential Cancer Immunotherapeutic Agent. Cancers 13:15, pages 3847.
Crossref
Christopher M. Wilson, Oscar E. Ospina, Mary K. Townsend, Jonathan Nguyen, Carlos Moran Segura, Joellen M. Schildkraut, Shelley S. Tworoger, Lauren C. Peres & Brooke L. Fridley. (2021) Challenges and Opportunities in the Statistical Analysis of Multiplex Immunofluorescence Data. Cancers 13:12, pages 3031.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.